DUBLIN, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...

Trinity Biotech plc, a biotechnology company specializing in human diagnostics and diabetes management, announced it has secured an additional $4 million in debt financing from Perceptive Advisors.

Microbes and fungi have long been nature's helpers in producing fine food, drinks and medicine, but new digital technologies could unlock far greater potential for the European biotech sector. Beer ...

In today’s fiercely competitive biotech industry, managing tight margins and evolving regulatory environments present major challenges. Add increased risks from geopolitical tensions, growing ...

Denali Therapeutics' proprietary Transport Vehicle technology enables drug delivery across the blood-brain barrier, targeting neurodegenerative diseases. DNL310, targeting MPS II, and DNL343 for ALS ...

Biotech stock Avalo Therapeutics (AVTX) skyrocketed to a two-year high Wednesday on positive results for its skin disease treatment and a subsequent $375 million offering. The company tested its drug, ...

MaxCyte granted Legend Biotech a non-exclusive worldwide license to use MaxCyte’s Flow Electroporation ® technology and ExPERT™ platform in connection with the research, clinical development, and ...

With finite natural resources and a growing demand for food, the world must find ways to overcome this challenge. One proposal comes from a Brazilian startup that will produce milk proteins without ...

In September 2024, Akeso, a little-known Chinese biopharmaceutical company, announced that clinical trials had shown that its new drug could halt the progression of a type of lung cancer for nearly a ...

Shares of No. 1 biotech stock Halozyme Therapeutics (HALO) bounded higher Wednesday after the biotech company obliterated second-quarter expectations. NOW PLAYING Biotech Stocks Are Shooting Higher.

Eupraxia Pharmaceuticals is developing clinical candidates that employ its DiffuSphere technology, which delivers treatments to the targeted tissues. The company's candidates are currently EP-104GI ...

This article is part of our Advanced Membership package. To enjoy unlimited access to The Long View from Vogue Business, The Fashion Exec's Guide and Market Insights Reports, sign up for Advanced ...